Revista de Medicina Desportiva (English) November 2018 | Page 15

will be easier”. The aim is to preserve the sport truth and the health of the athletes, with the innovation of the introduction of the awareness of all the participants on the sports, with new partnerships, greater reach of the target audience, fighting to the dis-information and spreading of innovative initiatives. It utilizes several methods, like brochures, vir- tual questionnaires, and e-mail and telephone contact. Although the existence of these campaigns, several athletes keep on trying to improve their physical capacity taking illicit methods and others are victims of involuntary doping when they unconscious con- sume forbitten substances included, for example, in the daily regular medication, being some of free sale at the pharmacies. In the World Antidoping Code it is described the three criteria to include a substance or method in the forbitten list, being necessary to meet two of the following criteria 1 : • To increase or to have the poten- tial to increase the sports perfor- mance • To Injury or to have the potential to injury the health of the practi- tioners • Get the sports spirit in risk. Clenbuterol is a sympathomi- metic substance that acts mostly on the ß2-adrenergetic receptors, and usually is prescribed for the symp- toms that aflicts the airway, as nasal decongestant and bronchodilator. With supratherapeutic doses this drug is used as a doping substance to increase the muscle mass of the athletes. Clenbuterol is not as potent as the androgenic anabolic steroids, however it can significantly increase the muscle mass of the athletes without having the typical side effects of anabolic steroids. 5 In this case, the substance was included on the the prescribed medi- cine as a therapeutic adjuvant to treat a respiratory infection. Since the athlete didn’t inform the doctor that he is a high-level sportsman, that could be submitted to a doping con- trol test, the TUE was nor requested or the choice for an alternative nor forbitten medicine and equally effective was not considered for the treatment. Although this a situation of involuntary doping, the athlete was sanctioned. After the notifica- tion of the positive result, a medical report was written and added to the prescription of the doctor to justify the consumption of the drug in order to have an attenuation of the sports penalty. This clinical case intends to remind the doctors and the athletes that “is duty of the sport practitioner to ensure that he doesn’t consume or any forbitten substance is intro- duced in his body or there isn’t the use of any forbitten method” 3 and that the forbitten substances can be found in several medications on the daily medical practice, and some are of free sale at the pharmacies. Whenever there is doubt about the security of a medication or sup- plement, there should consultation to the team doctor, to ADoP or to visit the site of this magazine in the section of “O medicamento é seguro?”, on the right column (https://www. revdesportiva.pt/). When an athlete needs to take a forbitten medica- tion a medical report should be made and to fill a form that can be downloaded from the net at ADoP site, indicating the diagnosis with relevant medical information and a clinical justification to take that forbitten medication and also the reason there aren’t other reasonable therapeutic alternatives. The doctor and the athlete must sign the form and send it by fax to the number 217977529, and they must wait for the answer to start the treatment, which usually takes 2 to 3 days. The contribution for clean sport is the responsibility of all of us, being necessary for that to have the knowledge and the spreading of the rules and laws in force about antidoping, that was the aim of this publication. sium Medica Portugal. Lisboa 2016. 2. Ribeiro B. O código Mundial Antidopagem. Rev. Medicina Desportiva Informa.2015; 6(2)10-15. 3. Lei n.º 38/2012 de 28 de agosto. Diário da República, 1.ª série – N.º 166. 4. Position of American Dietetic Association, Dietitians of Canada and American College of Sports Medicine: nutrition and athletic perfor- mance. Journal of the American Dietetic Association, Chicago, 2000; 100(12)1543-56. 5. Fragki, A. G. et al. Sport doping: Emerging designer and therapeutic b2 – Agonist. Clinica Chimica Acta, 2013; 425.242-258. The authors deny any conflict of interests Correspondence Dra. Telma Miragaia [email protected] Bibliography 1. Autoridade Antidopagem de Portugal. Guia prático sobre a luta contra a dopagem. Simpo- Revista de Medicina Desportiva informa november 2018 · 13